These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1779239

  • 21. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
    Kawamoto Y, Ito H, Ihara M, Takahashi R.
    Neuroreport; 2012 Feb 15; 23(3):162-7. PubMed ID: 22273571
    [Abstract] [Full Text] [Related]

  • 23. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.
    Chan-Palay V, Asan E.
    J Comp Neurol; 1989 Sep 15; 287(3):373-92. PubMed ID: 2570794
    [Abstract] [Full Text] [Related]

  • 24. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK.
    Neuroscience; 2000 Sep 15; 98(1):79-87. PubMed ID: 10858614
    [Abstract] [Full Text] [Related]

  • 25. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.
    Ala TA, Yang KH, Sung JH, Frey WH.
    J Neurol Neurosurg Psychiatry; 1997 Jan 15; 62(1):16-21. PubMed ID: 9010394
    [Abstract] [Full Text] [Related]

  • 26. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, Schapira AH.
    J Neurol Sci; 1998 Jun 11; 158(1):24-9. PubMed ID: 9667773
    [Abstract] [Full Text] [Related]

  • 27. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K, Iseki E, Uchiyama H, Watanabe Y, Haga T, Kameyama K, Ikeda T, Yamamoto T, Kosaka K.
    J Neurol Neurosurg Psychiatry; 1999 Aug 11; 67(2):209-13. PubMed ID: 10406992
    [Abstract] [Full Text] [Related]

  • 28. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
    Perry RH, Perry EK, Smith CJ, Xuereb JH, Irving D, Whitford CA, Candy JM, Cross AJ.
    J Neural Transm Suppl; 1987 Aug 11; 24():131-6. PubMed ID: 2824687
    [Abstract] [Full Text] [Related]

  • 29. Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study.
    Taylor JP, Firbank M, Barnett N, Pearce S, Livingstone A, Mosimann U, Eyre J, McKeith IG, O'Brien JT.
    Br J Psychiatry; 2011 Dec 11; 199(6):492-500. PubMed ID: 22016436
    [Abstract] [Full Text] [Related]

  • 30. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ, Broe GA, Halliday GM.
    Brain; 2002 Feb 11; 125(Pt 2):391-403. PubMed ID: 11844739
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Peripheral serotoninergic receptor sensitivity in senile dementia of the Alzheimer type.
    Thomas DR, Jones E, Warner N, Harris B, Williams P, Bentley P.
    Biol Psychiatry; 1988 Jan 15; 23(2):136-40. PubMed ID: 3334883
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR, Mountjoy CQ, Mann DM, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1989 Jun 15; 52(6):701-8. PubMed ID: 2545826
    [Abstract] [Full Text] [Related]

  • 35. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
    Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CC, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN.
    J Neurochem; 1983 Jul 15; 41(1):266-72. PubMed ID: 6306169
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S, Arai H, Matsushita S, Matsui T, Kimpara T, Takeda A, Shirakura K.
    Exp Neurol; 1998 Sep 15; 153(1):164-6. PubMed ID: 9743579
    [Abstract] [Full Text] [Related]

  • 39. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
    Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK.
    J Neurol Sci; 1995 Jul 15; 131(1):65-70. PubMed ID: 7561949
    [Abstract] [Full Text] [Related]

  • 40. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies.
    Owen AD, Schapira AH, Jenner P, Marsden CD.
    J Neural Transm Suppl; 1997 Jul 15; 51():167-73. PubMed ID: 9470137
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.